Literature DB >> 16681658

Refractory venous leg ulcers: a study of risk factors.

Guillaume Chaby1, Valérie Viseux, Albert Adrien Ramelet, Olivier Ganry, Anne Billet, Catherine Lok.   

Abstract

BACKGROUND: Although certain risk factors for poor healing of leg ulcers have been identified, data concerning the characteristics of refractory ulcers have not been specifically studied in the literature.
OBJECTIVE: To study the characteristics of refractory venous leg ulcers.
METHODS: We retrospectively studied prognostic factors for healing in patients with refractory venous leg ulcers followed and treated in our dermatology department between January 1993 and January 2000. Each patient included in this study was compared with two patients matched for age and gender and presenting leg ulcers with normal healing, followed during the same period.
RESULTS: Thirty-two of 571 patients with leg ulcers were included. The study population consisted of 20 females and 12 males with a mean age 73.5 years. The control population comprised 64 patients, 40 females and 24 males, with a mean age of 73 years. Univariate analysis demonstrated the negative prognostic impact of several previously identified factors (including surface area and history of the ulcer). In particular, multivariate analysis identified four main risk factors for refractory ulcer that are often associated in these patients: associated arterial disease, presence of post-thrombotic popliteal sequelae, recurrence of the ulcer, and disability.
CONCLUSION: Four main risk factors that are often associated were identified, indicating the multifactorial nature of these refractory ulcers.

Entities:  

Mesh:

Year:  2006        PMID: 16681658     DOI: 10.1111/j.1524-4725.2006.32104.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  5 in total

1.  Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection.

Authors:  Johanna M Sweere; Jonas D Van Belleghem; Heather Ishak; Michelle S Bach; Medeea Popescu; Vivekananda Sunkari; Gernot Kaber; Robert Manasherob; Gina A Suh; Xiou Cao; Christiaan R de Vries; Dung N Lam; Payton L Marshall; Maria Birukova; Ethan Katznelson; Daniel V Lazzareschi; Swathi Balaji; Sundeep G Keswani; Thomas R Hawn; Patrick R Secor; Paul L Bollyky
Journal:  Science       Date:  2019-03-29       Impact factor: 47.728

2.  Evaluation of the nano-oligosaccharide factor lipido-colloid matrix in the local management of venous leg ulcers: results of a randomised, controlled trial.

Authors:  Jean-Luc Schmutz; Sylvie Meaume; Ségolène Fays; Zohva Ourabah; Bernard Guillot; Valéne Thirion; Mark Collier; Simon Barrett; J Smith; Serge Bohbot; Anne Dompmartin
Journal:  Int Wound J       Date:  2008-06       Impact factor: 3.315

3.  The Canadian Bandaging Trial: Evidence-informed leg ulcer care and the effectiveness of two compression technologies.

Authors:  Margaret B Harrison; Elizabeth G Vandenkerkhof; Wilma M Hopman; Ian D Graham; Meg E Carley; E Andrea Nelson
Journal:  BMC Nurs       Date:  2011-10-13

4.  Superiority of a Novel Multifunctional Amorphous Hydrogel Containing Olea europaea Leaf Extract (EHO-85) for the Treatment of Skin Ulcers: A Randomized, Active-Controlled Clinical Trial.

Authors:  José Verdú-Soriano; Marisol de Cristino-Espinar; Silvia Luna-Morales; Caridad Dios-Guerra; Javier Caballero-Villarraso; Paloma Moreno-Moreno; Antonio Casado-Díaz; Miriam Berenguer-Pérez; Ipek Guler-Caamaño; Olga Laosa-Zafra; Leocadio Rodríguez-Mañas; José Luis Lázaro-Martínez
Journal:  J Clin Med       Date:  2022-02-25       Impact factor: 4.241

Review 5.  Four layer bandage compared with short stretch bandage for venous leg ulcers: systematic review and meta-analysis of randomised controlled trials with data from individual patients.

Authors:  Susan O'Meara; Jayne Tierney; Nicky Cullum; J Martin Bland; Peter J Franks; Trevor Mole; Mark Scriven
Journal:  BMJ       Date:  2009-04-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.